Department of Pharmaceutical Analysis, National Institute of Pharmaceutical Education and Research - Ahmedabad (NIPER-A), Opp. Airforce Station, Palaj, Gandhinagar, Gujarat 382355, India.
Department of Pharmaceutical Analysis, National Institute of Pharmaceutical Education and Research - Ahmedabad (NIPER-A), Opp. Airforce Station, Palaj, Gandhinagar, Gujarat 382355, India.
J Chromatogr A. 2023 Jan 25;1689:463725. doi: 10.1016/j.chroma.2022.463725. Epub 2022 Dec 20.
Hyphenation of different analytical techniques has always been advantageous in structural characterization as it saves time, money and resources. In the pharmaceutical sector, chromatography-based impurity profiling, including identification, characterization, and quantification in drug substances or finished products, is of utmost importance to comply with quality, patient safety and regulatory requirements. These impurities are monitored using LC-UV/DAD and identified and/or characterized using HRMS and MS/MS. LC analysis usually yields the area percent purity of the targeted peak, however, this is not sufficient for pharmaceutical purposes; where the regulatory requirement is to report impurities in percent weight by weight. Unfortunately, the non-availability of impurity standards and relative response factors at an early stage of drug development, risks the product quality due to the inability of the method to differentiate percent purity, and percent weight by weight. Hence, there is a need for a distinctive way of determining the relative response factor. In the current study, a unique hyphenation has been employed by integrating LC with DAD, CAD, and HRMS with hydrogen-deuterium exchange. The LC flow, post-DAD detection has been diverted to CAD with an inverse gradient for relative response factor determination and MS Orbitrap for exact mass, and MS fragmentation. A separate infusion pump has been incorporated to infuse DO on a need basis, which can perform partial hydrogen deuterium exchange for determining the number of labile hydrogens in the impurity structure. This hyphenation has been validated with four model compounds and a total of nineteen chromatographic peaks. The technique provides ample information for their qualitative analysis along with percent weight-by-weight values, which fulfils the regulatory requirements and can be used as one-stop solution for impurity profiling.
不同分析技术的联用在结构表征中一直具有优势,因为它可以节省时间、金钱和资源。在制药行业,基于色谱的杂质分析,包括药物原料或成品中的杂质的鉴定、特性描述和定量,对于符合质量、患者安全和监管要求至关重要。这些杂质使用 LC-UV/DAD 进行监测,并使用 HRMS 和 MS/MS 进行鉴定和/或特性描述。LC 分析通常会产生目标峰的面积百分比纯度,但这对于制药目的来说是不够的;监管要求以重量百分比报告杂质。不幸的是,在药物开发的早期阶段缺乏杂质标准和相对响应因子,由于方法无法区分百分比纯度和重量百分比,因此会存在产品质量风险。因此,需要有一种独特的方法来确定相对响应因子。在当前的研究中,通过将 LC 与 DAD、CAD 和 HRMS 与氢氘交换相结合,采用了一种独特的联用方法。LC 流动在 DAD 检测后被分流到 CAD 进行相对响应因子测定,采用逆梯度,MS Orbitrap 用于精确质量和 MS 碎片化。还合并了一个单独的输注泵,根据需要注入 DO,以进行部分氢氘交换,从而确定杂质结构中不稳定氢的数量。该联用方法已经用四种模型化合物和总共 19 个色谱峰进行了验证。该技术提供了充分的信息,可用于定性分析,以及重量百分比值,满足监管要求,并可用作杂质分析的一站式解决方案。